NCT03210090View on ClinicalTrials.gov

Impact of the Lack of CMV-Specific CD8+ T Cell Response in CMV-Seropositive Donors in CMV Reactivation After Hematopoietic Stem Cells Transplant in CMV-Seropositive Recipients

UnknownOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2019

Conditions
Cytomegalovirus InfectionHSCT
Trial Locations (2)

14004

RECRUITING

Hosìtal Universitario Reina Sofia, Córdoba

Unknown

RECRUITING

Hospital Marques de Valdecilla, Santander

Sponsors
All Listed Sponsors
collaborator

QIAGEN Gaithersburg, Inc

INDUSTRY

lead

Maimónides Biomedical Research Institute of Córdoba

OTHER